Pemphigus and Pemphigoid: From Disease Mechanisms to Druggable Pathways
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pemphigus and Pemphigoid: From Disease Mechanisms to Druggable Pathways
Authors
Keywords
-
Journal
JOURNAL OF INVESTIGATIVE DERMATOLOGY
Volume 142, Issue 3, Pages 907-914
Publisher
Elsevier BV
Online
2021-10-29
DOI
10.1016/j.jid.2021.04.040
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Milestones in Personalized Medicine in Pemphigus and Pemphigoid
- (2021) Katja Bieber et al. Frontiers in Immunology
- Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris
- (2021) Victoria P. Werth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of C3d immunohistochemical staining to ELISA and immunofluorescence for diagnosis of bullous pemphigoid
- (2020) Leo L. Wang et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Recent Advances in Understanding Pemphigus and Bullous Pemphigoid
- (2020) Christoph M. Hammers et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Dupilumab as a novel therapy for bullous pemphigoid: A multicenter case series
- (2020) Rana Abdat et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris
- (2020) Jinmin Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- C1s Inhibition by BIVV009 (Sutimlimab) Prevents Complement-Enhanced Activation of Autoimmune Human B Cells In Vitro
- (2019) Pavel A. Nikitin et al. JOURNAL OF IMMUNOLOGY
- Rituximab Therapy in Patients with Bullous Pemphigoid: A Retrospective Study of 20 Patients
- (2019) Maxim Polansky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Walnut antigens can trigger autoantibody development in patients with pemphigus vulgaris through a “hit-and-run” mechanism
- (2019) Lan Lin et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Bullous pemphigoid induced by ustekinumab: a case report
- (2019) Marta Marin et al. European Journal of Hospital Pharmacy-Science and Practice
- Mepolizumab failed to affect bullous pemphigoid: a randomized, placebo-controlled, double-blind phase 2 pilot study
- (2019) Dagmar Simon et al. ALLERGY
- A new ex vivo human oral mucosa model reveals that p38MAPK inhibition is not effective to prevent autoantibody-induced mucosal blistering in pemphigus
- (2019) D. T. Egu et al. BRITISH JOURNAL OF DERMATOLOGY
- Single-Cell Analysis Suggests that Ongoing Affinity Maturation Drives the Emergence of Pemphigus Vulgaris Autoimmune Disease
- (2019) Alice Cho et al. Cell Reports
- Complement Activation in Autoimmune Bullous Dermatoses: A Comprehensive Review
- (2019) Gareth Edwards et al. Frontiers in Immunology
- Rituximab is an Effective Treatment in Patients with Pemphigus Vulgaris and Demonstrates a Steroid‐Sparing Effect
- (2019) D.M. Chen et al. BRITISH JOURNAL OF DERMATOLOGY
- Mechanisms of Dupilumab
- (2019) Hani Harb et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Autoreactive B cell differentiation in diffuse ectopic lymphoid-like structures of inflamed pemphigus lesions
- (2019) Shengru Zhou et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Clinical outcome and safety of rituximab therapy for pemphigoid diseases
- (2019) Napatra Tovanabutra et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Factors Associated With Complete Remission After Rituximab Therapy for Pemphigus
- (2019) Carolyn J. Kushner et al. JAMA Dermatology
- The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid
- (2019) Kelly N. Messingham et al. Frontiers in Immunology
- Blocking FcRn in humans reduces circulating IgG levels and inhibits IgG immune complex–mediated immune responses
- (2019) L. J. Blumberg et al. Science Advances
- Mechanisms Causing Loss of Keratinocyte Cohesion in Pemphigus
- (2018) Volker Spindler et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Anti-C1s Antibody TNT003 Prevents Complement Activation in the Skin Induced by Bullous Pemphigoid Autoantibodies
- (2018) Anika Kasprick et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Autoantibody Signaling in Pemphigus Vulgaris: Development of an Integrated Model
- (2018) Thomas Sajda et al. Frontiers in Immunology
- Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2
- (2018) Christian M. Karsten et al. Frontiers in Immunology
- IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid
- (2018) Lenche Chakievska et al. JOURNAL OF AUTOIMMUNITY
- Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans
- (2018) Peter Ulrichts et al. JOURNAL OF CLINICAL INVESTIGATION
- Autoreactive IgG and IgA B Cells Evolve through Distinct Subclass Switch Pathways in the Autoimmune Disease Pemphigus Vulgaris
- (2018) Christoph T. Ellebrecht et al. Cell Reports
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid
- (2017) Teruki Dainichi et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Non-pathogenic pemphigus foliaceus (PF) IgG acts synergistically with a directly pathogenic PF IgG to increase blistering by p38MAPK-dependent desmoglein 1 clustering
- (2017) Kenji Yoshida et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
- (2017) Pascal Joly et al. LANCET
- Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009—Results from a Randomized First-in-Human Phase 1 Trial
- (2017) Jakob Mühlbacher et al. TRANSPLANTATION
- Proteomic Analysis of Pemphigus Autoantibodies Indicates a Larger, More Diverse, and More Dynamic Repertoire than Determined by B Cell Genetics
- (2017) Jing Chen et al. Cell Reports
- Pemphigus
- (2017) Michael Kasperkiewicz et al. Nature Reviews Disease Primers
- Mechanisms of Disease: Pemphigus and Bullous Pemphigoid
- (2016) Christoph M. Hammers et al. Annual Review of Pathology-Mechanisms of Disease
- Determinants of VH1-46 Cross-Reactivity to Pemphigus Vulgaris Autoantigen Desmoglein 3 and Rotavirus Antigen VP6
- (2016) Michael Jeffrey Cho et al. JOURNAL OF IMMUNOLOGY
- A successful treatment with ustekinumab in a case of relapsing bullous pemphigoid associated with psoriasis
- (2016) J. Loget et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Combined integrated protocol/basket trial design for a first-in-human trial
- (2016) Ulla Derhaschnig et al. Orphanet Journal of Rare Diseases
- Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease
- (2016) C. T. Ellebrecht et al. SCIENCE
- First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid
- (2015) Y.T. Cho et al. BRITISH JOURNAL OF DERMATOLOGY
- Development of bullous pemphigoid during treatment of psoriatic onycho-pachydermo periostitis with ustekinumab
- (2015) Chihiro Nakayama et al. JOURNAL OF DERMATOLOGY
- Persistence of Anti-Desmoglein 3 IgG + B-Cell Clones in Pemphigus Patients over Years
- (2015) Christoph M. Hammers et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Desmosomal Cadherins and Signaling: Lessons from Autoimmune Disease
- (2014) Volker Spindler et al. CELL COMMUNICATION AND ADHESION
- Innate Immune Cell–Produced IL-17 Sustains Inflammation in Bullous Pemphigoid
- (2014) Sébastien Le Jan et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Omalizumab therapy for bullous pemphigoid
- (2014) Kenneth K. Yu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Shared VH1-46 gene usage by pemphigus vulgaris autoantibodies indicates common humoral immune responses among patients
- (2014) Michael Jeffrey Cho et al. Nature Communications
- A higher correlation of the antibody activities against the calcium-dependent epitopes of desmoglein 3 quantified by ethylenediaminetetraacetic acid-treated enzyme-linked immunosorbent assay with clinical disease activities of pemphigus vulgaris
- (2013) Koji Kamiya et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Association of Serum B-Cell Activating Factor Level and Proportion of Memory and Transitional B Cells with Clinical Response after Rituximab Treatment of Bullous Pemphigoid Patients
- (2013) Russell P. Hall et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- MAPKAP Kinase 2 (MK2)-Dependent and -Independent Models of Blister Formation in Pemphigus Vulgaris
- (2013) Xuming Mao et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies
- (2013) Maria J Leandro ARTHRITIS RESEARCH & THERAPY
- Enrichment of total serum IgG4 in patients with pemphigus
- (2012) T. Funakoshi et al. BRITISH JOURNAL OF DERMATOLOGY
- Regulation of CD20 in Rituximab-Resistant Cell Lines and B-cell Non-Hodgkin Lymphoma
- (2012) P.-C. Tsai et al. CLINICAL CANCER RESEARCH
- Inhibitory human antichimeric antibodies to rituximab in a patient with pemphigus
- (2012) Luisa Lunardon et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface
- (2012) Giovanni Di Zenzo et al. JOURNAL OF CLINICAL INVESTIGATION
- Cutting Edge: Brazilian Pemphigus Foliaceus Anti-Desmoglein 1 Autoantibodies Cross-React with Sand Fly Salivary LJM11 Antigen
- (2012) Y. Qian et al. JOURNAL OF IMMUNOLOGY
- Epitope Spreading Is Rarely Found in Pemphigus Vulgaris by Large-Scale Longitudinal Study Using Desmoglein 2–Based Swapped Molecules
- (2012) Bungo Ohyama et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases
- (2012) Erwin W. Gelfand NEW ENGLAND JOURNAL OF MEDICINE
- Signaling Dependent and Independent Mechanisms in Pemphigus Vulgaris Blister Formation
- (2012) Masataka Saito et al. PLoS One
- Immune response towards the amino-terminus of desmoglein 1 prevails across different activity stages in nonendemic pemphigus foliaceus
- (2010) P.T. Chan et al. BRITISH JOURNAL OF DERMATOLOGY
- Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients
- (2010) Enno Schmidt et al. EXPERIMENTAL DERMATOLOGY
- Human IgG1 Monoclonal Antibody against Human Collagen 17 Noncollagenous 16A Domain Induces Blisters via Complement Activation in Experimental Bullous Pemphigoid Model
- (2010) Q. Li et al. JOURNAL OF IMMUNOLOGY
- Blockade of Autoantibody-Initiated Tissue Damage by Using Recombinant Fab Antibody Fragments against Pathogenic Autoantigen
- (2009) Gang Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- Antibodies to the Desmoglein 1 Precursor Proprotein but Not to the Mature Cell Surface Protein Cloned from Individuals without Pemphigus
- (2009) J. Yamagami et al. JOURNAL OF IMMUNOLOGY
- Antigen Selection of Anti-DSG1 Autoantibodies During and Before the Onset of Endemic Pemphigus Foliaceus
- (2009) Ye Qian et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A randomized double-blind trial of intravenous immunoglobulin for pemphigus
- (2009) Masayuki Amagai et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid
- (2008) Giovanni Di Zenzo et al. CLINICAL IMMUNOLOGY
- B-Cell Depletion Immunotherapy in Pemphigus: Effects on Cellular and Humoral Immune Responses
- (2008) Hugo Mouquet et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Isolation of Pathogenic Monoclonal Anti-Desmoglein 1 Human Antibodies by Phage Display of Pemphigus Foliaceus Autoantibodies
- (2007) Ken Ishii et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More